None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Histologically diagnosed endometrioid type patient 2) Patients who underwent hysterectomy and surgical staging 3) Patient who corresponds to FIGO Stage III in surgical pathology examination 4) Patients undergoing or planning to undergo systemic chemotherapy 5) Adults between 20 and 80 years of age 6) Whole body performance before participation in the study was ECOG 0-1 7) When the patient voluntarily writes a consent form
Exclusion criteria
Exclusion criteria: 1) Patients with distant metastases 2) Patients who have previously received pelvic radiation therapy 3) In case of untreated serious acute disease other than endometrial cancer 4) In case of recurrence or recurrence within 5 years after diagnosis of other cancers except for thyroid cancer and skin cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival rate when hypofractionated intensity modulated radiotherapy is applied after surgery for endometrial cancer;Acute grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer;Chroni grade 3 or higher side effects when hypofractionated intensity-modulated radiotherapy is applied after surgery for endometrial cancer | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center